Information sur le cancer / Types de cancer / Bassinet du rein et uretère / Cancers du bassinet du rein et de l'uretère / Tumeurs cancéreuses

Feldman AS, Efstathiou JA, Lee RJ, Dahl DM, Michaelson MD, Zietman AL. Cancer of the bladder, ureter, and renal pelvis. DeVita VT Jr, Lawrence TS, Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Édition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 65:896-916.

Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs - Part B: Prostate and Bladder Tumours. (2016, July). European Urology. 70(1):106-119. Extrait de: https://www.europeanurology.com/article/S0302-2838(16)00205-0/fulltext.

Jarrard DF. (2016, September 18). Medscape Reference: Urothelial Tumors of the Renal Pelvis and Ureters. Extrait de: https://emedicine.medscape.com/article/452449-overview.

Leow JJ, Chong KT, Chang SL, Bellmunt J. Upper tract urothelial carcinoma: a different disease entity in terms of management. (2017). ESMO Open. 1:e000126. Extrait de: https://esmoopen.bmj.com/content/1/6/e000126.

Mark JR. Renal pelvic and ureteral cancers. Porter RS (ed.). (2017, October). Merck Manual Professional Edition. Kenilworth, NJ: Merck Sharp & Dohme Corp. Accessed November 8, 2018. Extrait de: https://www.merckmanuals.com/en-ca/professional/genitourinary-disorders/genitourinary-cancer/renal-pelvic-and-ureteral-cancers.

National Cancer Institute. (2018, February 7). Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®) Health Professional Version. Extrait de: https://www.cancer.gov/types/kidney/hp/transitional-cell-treatment-pdq.